Trials / Not Yet Recruiting
Not Yet RecruitingNCT07436221
A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Asthma
A Randomized, Double-blind, Phase II Clinical Study to Evaluate the Efficacy and Safety of AK139 in the Treatment of Participants With Moderate to Severe Asthma
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 160 (estimated)
- Sponsor
- Akeso · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, double-blind phase II clinical study to evaluate the efficacy and safety of AK139 in the treatment of participants with moderate to severe asthma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AK139 | AK139 regimen 1- subcutaneous injection. |
| DRUG | AK139 | AK139 regimen 2- subcutaneous injection. |
| DRUG | AK139 | AK139 regimen 3- subcutaneous injection. |
| DRUG | Placebo | subcutaneous injection. |
Timeline
- Start date
- 2026-02-28
- Primary completion
- 2026-12-27
- Completion
- 2027-02-26
- First posted
- 2026-02-27
- Last updated
- 2026-02-27
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT07436221. Inclusion in this directory is not an endorsement.